AGP Executive Report

Medicaid Fraud Crackdown: Three people were convicted and sentenced in Kentucky for nearly $5M in Medicaid/Medicare fraud tied to addiction treatment clinics, including billing for services not provided and using a doctor’s DEA credentials to prescribe Suboxone. Patient Safety & Recalls: The FDA classified a nationwide Levothyroxine recall as Class II due to subpotency, listing multiple affected lots and expiration dates. New ADHD Option: Otsuka’s Simtriyo (centanafadine) won FDA approval for ADHD in adults and children 6+, with availability expected later this year after controlled-substance scheduling. Clinical Care in Primary Settings: A large trial in JAMA Pediatrics found family-based childhood obesity treatment can work in primary care practices, with meaningful weight improvements lasting at least 18 months. Health System Access Pressure: New York hospitals and UnitedHealthcare are again facing an Aug. 1 deadline for contract talks, with patients already at risk of being out of network. Public Health Preparedness: Canada announced a new medical countermeasures lab facility in Winnipeg. Bioelectronics Breakthrough: Feinstein Institutes released a comprehensive human vagus nerve anatomical map to support neuromodulation research. Rural Transport Strain: Colorado Medicaid non-emergency medical transportation cuts are reducing ride options for rural patients.

Pediatric Dengue Warning: Sri Lankan health authorities urged parents to seek prompt care if a child’s fever lasts over 24 hours, warning that late hospital arrival and home remedies can be deadly. Drug Discovery Infrastructure: Monash University and the Australian Synchrotron will launch a $2.9M robotic platform to speed up medicine invention and testing using high-throughput X-ray crystallography. Periodontitis Treatment Research: A new study highlights blocking host-cell invasion pathways for Porphyromonas gingivalis, with simvastatin emerging as a potential antibiotic adjuvant in a rat model. Medication Waste Cut: UK’s Clatterbridge Cancer Centre won £583,000 to develop “Pharmabag,” a safer way to reuse unopened medicines and reduce waste. AI in Healthcare Info: A large study finds YouTube medical content with more clickbait draws more viewers but tends to be lower in clinical quality. Medical Access in Remote Areas: India’s PHC Mogla in Rajouri is providing free medicines, diagnostics, and bedside X-rays to cut long travel for rural patients. Public Health Safety Alerts: Macao authorities recalled a specific infant formula batch after lead levels exceeded limits, urging medical help if symptoms appear. Ebola Surge: DRC Ebola cases rose to 3,200 with 1,405 deaths as response teams struggle to reach affected areas. Oral Cancer Awareness: Doctors marked World Head and Neck Cancer Day by urging people not to ignore non-healing mouth ulcers, red/white patches, or reduced mouth opening.

Aviation Medical Emergency: A Ryanair flight from Birmingham to Dublin declared an emergency after a medical incident onboard, diverting for priority landing and landing safely with crews on standby. Nutrition & Prevention: New reporting highlights foods that can beat grapefruit for vitamin C, while separate studies suggest time-restricted eating may help preserve cognitive function and that unsweetened sparkling water may be gentler on tooth enamel than soda. Healthcare Access & Policy: Delta is changing rules that previously required minimum separation between pharmacies and clinics, aiming to support integrated care models; in the U.S., a proposed CMS rule could cut Virginia Medicaid spending by $31B, and a lobbying push wants Medicare to cover grab bars to reduce fall injuries. HIV Prevention Breakthroughs: Merck is planning earlier access licensing for an investigational once-monthly oral PrEP option (MK-8527) across low- and middle-income countries ahead of phase 3 completion. Mental Health Treatment: The UAE’s Emirates Health Services says it has started using a once-every-six-months schizophrenia medication (BYANNLI). Medical Tech & Billing: Candid Health raised $120M for an AI revenue cycle management platform. Research & Safety: Real-world AML data suggest venetoclax dose changes and drug interactions may not harm response durability; separate work identifies brainstem neurons as a potential target to reverse fentanyl respiratory depression. Legal & Ethics: The DOJ accused UC San Diego School of Medicine of racial discrimination in admissions; a class action was filed against Regeneron over claims about a Phase III study. Public Health Warnings: UK regulators urge people to store medicines properly in summer to avoid heat damage. Care in the Real World: A hiker died after a collapse in New Hampshire despite CPR and airlift; and a new program in Iowa targets “high-utilizers” with serious mental illness to break cycles of homelessness, jail, and hospitals.

Medicines Funding Push (New Zealand): ACT wants Pharmac’s budget to rise by 1% of the health budget each year, reaching 12% by 2033 to close New Zealand’s medicines gap with Australia and fund more drugs on Pharmac’s investment list. Patient Safety & Access (Pakistan): Pakistan’s cabinet committee approved prices for 52 newly registered life-saving medicines, including cancer and diabetes treatments, clearing the way for DRAP notifications. Medicare Costs Shock (US): A retiree who took a large pension buyout faced a much higher Medicare Part B premium after Medicare’s two-year income review flagged the payout as taxable income. Legal Accountability (India): Kerala’s Human Rights Commission said criminal cases against private hospitals should be filed only after an expert medical panel establishes negligence. Care Quality Debate (US/UK): New research claims low-dose lithium may help fight early Alzheimer’s, while experts caution that multivitamin benefits are mixed. Screening Caution (US): Whole-body MRI screenings are gaining popularity, but major groups warn they can trigger unnecessary follow-up tests and treatment. Health Policy (Canada): Ontario expands pharmacists’ roles to assess and prescribe for more common ailments and add more publicly funded vaccines. Community Health (US): A back-to-school event in Kansas City paired school supplies with immunization and Medicaid rule updates.

AI & Patient Safety: A Florida pastor sued OpenAI after he says ChatGPT downplayed symptoms of a pulmonary embolism, delaying care and leading to an ICU stay; the suit also targets ChatGPT Health’s use of medical records. Weight-loss Access: Medicare launched a GLP-1 Bridge Program for Part D enrollees, offering fixed $50 monthly copays for weight-loss GLP-1s through Dec. 31, 2027—an interim fix that could leave seniors exposed when it ends. Drug Recalls: The FDA recalled certain lots of cetirizine after possible cross-contamination with ranitidine, warning of potentially life-threatening allergic reactions. Public Health Nutrition: A controlled trial found teens who eat breakfast—especially higher-protein breakfasts—take in more key nutrients and less high-fat, high-sugar foods. Mental Health: Research links suicidal thinking in people with psychosis more to distress from hallucinations/delusions—via anxiety and feeling trapped—than to symptom presence alone. Global Health & Pharma: Aurobindo Pharma signed a royalty-free voluntary license with MSD to supply generic alimatravir for HIV prevention across eligible low- and middle-income countries. Conflict & Care: Israeli strikes in Gaza reportedly killed a senior Hamas-led police official and a medic, underscoring ongoing risks to health workers.

Medical Education & Workforce: Miami-Dade opened a Career Dual Enrollment Medical Assisting Lab at South Miami Senior High with South Dade Technical College, letting students earn certifications and hands-on training before graduation. Healthcare Access & Care Delivery: A new Milwaukee Trauma Recovery Center is planned at ThriveOn King, aiming to provide free mental health support for survivors of violent crime and injury. Pediatric Emergency Medicine: A child’s life was saved after peanut fragments blocked his airway; doctors performed an emergency bronchoscopy to remove the debris. FDA Safety Alerts: Multiple allergy and thyroid medicines were recalled nationwide after possible contamination or mix-ups, including cetirizine tablets potentially containing another drug. Medicare Policy: A bipartisan Patients First Act would modernize the Medicare Physician Fee Schedule with inflation updates and payment reforms, though surgeons say key issues remain. Fraud & Accountability: DOJ prosecutors say four men used AI-made records to steal about $2.2M from Minnesota Medicaid housing programs. Pharma & Regulation: Canada’s pharma task force urges Health Canada to lean on foreign regulator reviews and boost health data infrastructure amid geopolitical pressure. Global Health & Logistics: Africa’s pharma supply chain is under renewed scrutiny as Ebola outbreaks expose cross-border bottlenecks and cold-chain risks. Clinical Research: A small trial suggests fecal transplants may improve sleep in adults with chronic insomnia for up to six months. Compounding & Peptides: An FDA advisory panel narrowly backed easing restrictions for several unapproved peptides to be allowed for pharmacy compounding.

Legal Proceedings: Singer D4vd is back in court as a medical examiner resumes testimony in the Celeste Rivas Hernandez murder case, with autopsy findings pointing to homicide by penetrating injuries. Health Policy (Canada): Canada’s Pharmaceutical and Life Sciences Sector Task Force wraps up, urging steps to improve affordability, supply security, and innovation as the government reviews recommendations. Insurance & Access (US): A Colorado woman says Medicare Advantage denied claims because her name is too long for character limits on insurance cards, triggering coverage problems. Medication Safety (US): The FDA says a nationwide recall is underway for certain lots of levothyroxine sodium tablets from Major Pharmaceuticals due to subpotency. GLP-1 Guidance & Culture: Kroger rolls out a GLP-1 support program with diet tips, while a National Confectioners Association study argues GLP-1 users still engage with confectionery markets. Foodborne Outbreak (US): New Hampshire reports confirmed cyclosporiasis cases tied to recalled Taylor Farms lettuce from a Cheshire Medical Center cafeteria. FDA Compounding: An FDA advisory panel voted to exclude peptide emideltide from a list that would broaden pharmacy compounding. Global Politics & Health: Guinea-Bissau’s opposition leader Domingos Simoes Pereira is allowed to travel to Portugal for medical treatment after prison release. Care Delivery (India): Nagaland launches a GPS-enabled mobile medical unit for Noklak to expand primary care in remote areas. Military Medicine (Ukraine): Ukraine reports shortages of combat medics and surgical staff, expanding basic medical training to address gaps.

Mental Health Drug Update: Actinogen Medical says its Phase 2 proof-of-concept for Xanamem (emestedastat) in difficult-to-treat major depressive disorder showed clinically meaningful improvement, with benefits strengthening by week 10. Digital Health Expansion: OpenAI is rolling out “Health in ChatGPT” for U.S. adults, letting users securely connect Apple Health and certain medical records for more personalized answers. FDA/Compounding Controversy: An FDA advisory panel backed adding four peptides to the 503A “Bulks List,” despite safety concerns and limited human data, raising the odds of wider compounding use. Cancer Drug Pipeline: Revolution Medicines reports the FDA accepted its NDA for daraxonrasib in previously treated metastatic pancreatic cancer, supported by Phase 3 results. Wearables Meet Cardiology: WHOOP named cardiologist Ami Bhatt as chief medical officer to strengthen clinical grounding of its consumer health features. Patient Safety & Privacy: SA Health is investigating alleged inappropriate access to AFL star Tony Modra’s records by staff. Access & Coverage Pressure: Britain’s ADHD prescribing is rising fast, while experts warn the trend may be “medicalising childhood.” Medicare GLP-1 Debate: Experts say Medicare’s new GLP-1 bridge program may lack age-specific safety guardrails for older adults. Pharmacy Business Reality: Independent pharmacies in England say they’re being left out of business rates relief that benefits other venues, adding pressure to stay open.

AI & Patient Safety: A Florida pastor is suing OpenAI, alleging ChatGPT-4o discouraged him from seeking care before a near-fatal pulmonary embolism. Medicare GLP-1 Access: Medicare’s new $50/month GLP-1 “Bridge” for weight loss launched July 1, but it expires Dec. 31, 2027, leaving patients facing an uncertain cutoff. Drug Pricing & Tariffs: Reuters reports early Medicare obesity-drug demand is shifting toward injections, while Trump’s proposed steep generic tariffs are rattling Indian pharma and supply-chain plans. Health Coverage & Fraud: Maine’s Medicare Fraud Control Unit was given 60 days to fix performance gaps or risk losing certification. Care Access on the Ground: CommonGood Medical is expanding in McKinney, Texas, to serve uninsured adults in a fast-growing county. Public Health & Logistics: North Carolina is funding nearly $400,000 to expand long-distance medical transportation via a Wave Transit/New Hanover consolidation. Community Health: WHO and Zambia are preparing a nationwide survey to improve access to neurological and mental health medicines. Food Safety: A UK milk recall warns of possible veterinary medicines, including antibiotics, for people with antibiotic allergies.

Precision Medicine Rollout: Tempus launched national OneOme pharmacogenomics testing, adding 27-gene and single-gene options to help clinicians gauge medication safety, dosing, and toxicity risk. Digital Health Leadership: WHOOP named cardiologist Dr. Ami Bhatt as Chief Medical Officer to steer its consumer health push with clinical and AI oversight. Policy & Access: The U.S. House passed Energy and Commerce bills aimed at reauthorizing public health programs, expanding workforce support, and speeding access to medical innovation. Medication Safety: FDA flagged a cetirizine recall after cross-contamination with ranitidine, warning of potentially life-threatening reactions for some allergy sufferers. Medicaid Shockwaves: Multiple reports highlight Medicaid payment freezes and fraud crackdowns, while Kentucky Gov. Beshear moved $255M in surplus funds to prevent a 4% cut. Global Supply & Trade: Trump’s proposed steep generic-drug tariffs from 2028 rattled Indian pharma, with analysts warning of higher costs and export pressure. Health Systems Capacity: Zimbabwe’s China-aided National Pharmaceutical Warehouse is boosting storage and distribution since 2022.

Medicaid Crackdown: HHS is freezing more than $1B in Medicaid payments to California and Minnesota over suspected fraud and documentation gaps, with states facing demands for proof before funds are released. Work Requirements Pressure: North Dakota is preparing to apply 80-hours-per-month work rules to some Medicaid Expansion adults starting Jan. 2027, with thousands potentially affected. Hospital Funding Fight: Texas children’s hospitals are urging CMS to reconsider proposed Medicaid rules they say could slash access to lifesaving pediatric care. Nursing Contract Tension: Thousands of Boston Medical Center nurses plan pickets over wages, insurance costs, and staffing strain, pushing for a new union contract. Drug Pricing Politics: A new Public Citizen argument says Medicare should negotiate drug prices at launch to prevent manufacturers from setting high initial prices and raising them repeatedly. Generic Drug Tariffs: Trump’s plan for steep tariffs on imported generics (100% from Aug 2028, up to 200% later) is already drawing warnings about higher medicine costs. Fraud and Enforcement: A Coeur d’Alene doctor was sentenced in a Medicare fraud case tied to telemedicine genetic tests and braces; separately, an FBI capture ended a years-long hunt for a fugitive accused in a $547M Medicare scheme. Safety Alerts: A cetirizine allergy medicine recall is underway after contamination concerns involving ranitidine. Global Health Aid: India delivered the first 4.5 tonnes of Ebola-related medical supplies to Kenya to strengthen preparedness.

Medicaid Crackdown: The Trump administration is deferring more than $1B in Medicaid payments to California and Minnesota over suspected fraud and “noncompliance,” drawing sharp pushback from lawmakers and advocates who warn it could disrupt care for vulnerable seniors. Drug Pricing & Supply: Trump announced steep phased tariffs on imported generic medicines—0% for two years starting Aug 1, 2026, then 100% and 200%—a move aimed at reshoring manufacturing that could hit India, a major generic exporter. GLP-1 & Alcohol Use Disorder: A BMJ Open study links newer GLP-1 drugs (semaglutide or tirzepatide) to fewer alcohol-related hospital admissions in adults with alcohol-use disorder. Health Equity in Admissions: Federal investigators opened a civil rights probe into East Carolina University’s medical school admissions for alleged racial discrimination. Community Care Access: Niagara Falls Memorial Medical Center will expand outreach with Niagara Pride via a monthly mobile health unit. Public Health Alert: FDA is still investigating the cyclosporiasis outbreak after earlier test results were a false positive, while local health officials urge food and hygiene precautions. New Treatments in the Pipeline: Nature Medicine reports promising safety/tolerability results for personalized allele-selective antisense oligonucleotides in SCN2A-related disease, and Lancet Gastroenterology & Hepatology publishes rapid biomarker improvements at 12 weeks for zabopegdutide in MASLD/MASH. Pharmacy Safety: A nationwide allergy medication recall was issued over possible cross-contamination that could trigger life-threatening reactions.

Weight-loss ad lawsuit: Novo Nordisk is suing Eli Lilly over “false and materially misleading” weight-loss and diabetes ads, accusing Lilly of using outdated study comparisons and burying key context. Policy & access: Spain’s Council of Ministers approved a draft Medicines and Health Products law that changes how medicines are financed and aims to reduce supply shortages. Counterfeit/food safety: The U.S. FDA and CDC are tracking a cyclospora outbreak tied to shredded iceberg lettuce from Taylor Farms, after a prior positive test was later deemed a false alarm; Michigan reports thousands of cases. Clinical trial progress: Envoy Medical says all 56 patients hit the three-month milestone in its pivotal Acclaim cochlear implant trial as it works toward an FDA PMA submission. Healthcare business moves: Fresenius Medical Care launched TherapyWise Analytics to help clinicians optimize kidney replacement therapy using cloud-based insights. Community health: Azerbaijan repatriated 16 people from Syria and provided initial medical and psychosocial support. Care delivery expansion: CVS will now dispense select pet prescriptions at thousands of stores. Global health workforce: BRICS nations agreed to create a working group on traditional, complementary and integrative medicine.

Biotech Deal: Samsung Biologics is set to buy Swiss peptide maker PolyPeptide for about $1.8B, aiming to expand into peptide therapies and GLP-1 manufacturing. Medicare Policy Fight: A Senate vote kept Washington’s AI-based Medicare coverage pilot (WISeR) running, despite claims it could deny care. Oncology Research: UT Southwestern and UAB report a strategy where pretreating glioblastoma with EGFR inhibitors before temozolomide made tumors far more sensitive in lab and mouse models. Gene Therapy Milestone: The FDA expanded CRISPR gene therapy Casgevy for sickle cell disease to children as young as 2. Diabetes Breakthrough: A stem-cell approach in mice reversed newly diagnosed Type 1 diabetes by reprogramming the immune system. Public Health Watch: El Paso is investigating seven cyclosporiasis cases tied to explosive diarrhea, with no single source yet identified. Healthcare Access & Safety: DOJ says UC San Diego medical school used an unlawful “shadow application” process favoring race in admissions. Workforce & Training: UVM Medical Center earned an ANCC Well-being Excellence Credential for employee-driven wellbeing efforts.

Regulatory Watch: India’s CDSCO has approved QDENGA, Takeda’s dengue vaccine, for ages 4–60—an important step as dengue cases and deaths remain high. Policy & Access: Wisconsin begins implementing a law extending postpartum Medicaid coverage from 60 days to a year, aiming to reduce gaps in care and prevent avoidable deaths. Clinical Breakthrough: A Michigan Medicine-led trial found a daily heart-failure polypill improved cardiac function and cut hospital/ER visits by 60%, published in Nature Medicine. Public Health & Outbreak Response: WHO is enrolling its first treatment trial for the Bundibugyo Ebola strain in Congo, testing MBP-134 and remdesivir. Healthcare Systems & Safety: South Dakota’s rural EMS funding fight escalates as Rapid City’s fire department warns it may stop covering rural areas after 2026 without new funding. Pharma & Industry: Samsung Biologics announced a CHF 1.46B acquisition of PolyPeptide to scale peptide manufacturing, targeting growing demand tied to obesity and diabetes therapies. Medical Ethics & Courts: India’s Delhi High Court orders Safdarjung Hospital to file Sonam Wangchuk’s medical reports and will decide Tuesday on a request to move him to a private facility.

Chinese Medicine Global Push: Hong Kong’s ICMCM conference (Aug 13–15) is drawing international experts to speed “clinical translation” and expand Chinese medicine’s global reach. Pakistan–China Pharma Links: Officials highlight new Sino-Pak cooperation structures to boost herbal and TCM research, training, and innovation. COVID Update (India): Andhra Pradesh reports a fresh uptick and points to a home-based protocol from 2021 that cut hospitalisations in mild cases; meanwhile Maharashtra sees rising, mostly mild cases after years of low activity. Neonatal Care Tool: Doctors in Jaipur report that the CRIB-II score can quickly flag high-risk premature newborns and guide early treatment. Medicinal Cannabis Oversight (NZ): A Canterbury supplier faces charges after police allege cannabis use outside licence terms. Drug Access (Pakistan): About 40 registered medicines remain unavailable due to pending price approvals, pushing patients toward costly imports. Medicare Costs (US): New reporting explains how Roth conversions can trigger higher Medicare premiums via the IRMAA “two-year lookback.” Healthcare Equity (US): The EEOC sues UT Medical Branch over alleged equal-pay violations. Medical Devices Safety: A new investigation spotlights serious flaws in how some consumer medical devices are sold and regulated, including reported burns.